KeywordsIntestinal Metaplasia Esophageal Adenocarcinoma High Grade Dysplasia GERD Symptom Argon Plasma Coagulation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM (2002) Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology: 26–33Google Scholar
- Sharma P, Weston A, Keeton S, Camargo L, Sampliner RE (2001) Control of esophageal acid exposure in patients with Barrett’s esophagus on rabeprazole. Am J Gastroenterol 96: S36(110)Google Scholar
- Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L et al (1997) Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophagogastric junction. Comparison between early cancer in Barrett’s esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 10: 190–195PubMedGoogle Scholar
- May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G et al (2002) Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Heptaol 14: 1085–1091CrossRefGoogle Scholar
- Overholt B, Lightdale C, Wang K, Canto M, Burdick S, Barr H et al (2003) International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett’s esophagus (BE): results of 24-month follow-up. Gastroenterology 124: A20CrossRefGoogle Scholar
- Buttar NS, Wang KK, Burgart LJ, Song LMMWK, Lutzke LS, Wandersee SM et al (2003) Endoscopic appearance and extent of high-grade dysplasia in Barrett’s esophagus can predict the presence of cancer at esophagectomy. Am J Gastroenterol 98(9 Suppl): S28(81)Google Scholar
- Reid B, Prevo L, Galipeau P, Sanchez CA, Longton G, Levine D et al (2001) Predictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96: 2839–2848PubMedCrossRefGoogle Scholar
- El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE (2004) Proton pump inhibitors are associated with reduced incidence of dysplasia. Am J Gastroenterol (in press)Google Scholar
© Springer-Verlag/Wien 2006